Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mirum Pharmaceuticals (MIRM) Profit After Tax: 2019-2024

Historic Profit After Tax for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Dec 2024 value amounting to -$87.9 million.

  • Mirum Pharmaceuticals' Profit After Tax rose 120.41% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.4 million, marking a year-over-year increase of 58.50%. This contributed to the annual value of -$87.9 million for FY2024, which is 46.18% up from last year.
  • According to the latest figures from FY2024, Mirum Pharmaceuticals' Profit After Tax is -$87.9 million, which was up 46.18% from -$163.4 million recorded in FY2023.
  • In the past 5 years, Mirum Pharmaceuticals' Profit After Tax ranged from a high of -$84.0 million in FY2021 and a low of -$163.4 million during FY2023.
  • Its 3-year average for Profit After Tax is -$129.0 million, with a median of -$135.7 million in 2022.
  • Per our database at Business Quant, Mirum Pharmaceuticals' Profit After Tax plummeted by 96.51% in 2020 and then surged by 46.18% in 2024.
  • Over the past 5 years, Mirum Pharmaceuticals' Profit After Tax (Yearly) stood at -$103.3 million in 2020, then increased by 18.67% to -$84.0 million in 2021, then slumped by 61.53% to -$135.7 million in 2022, then decreased by 20.45% to -$163.4 million in 2023, then surged by 46.18% to -$87.9 million in 2024.